Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: The ‘GISCAD-alternating schedule’ study findings-Reference-Cited by-同舟云学术

Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: The ‘GISCAD-alternating schedule’ study findings

Published:2009-01 Issue:1 Volume:45 Page:65-73
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Mandalà Mario,Barni Sandro,Floriani Irene,Isa Luciano,Fornarini Giuseppe,Marangolo Maurizio,Mosconi Stefania,Corsi Domenico,Rulli Eliana,Frontini Luciano,Cortesi Enrico,Zaniboni Alberto,Aglietta Massimo,Labianca Roberto

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study;Cohen;Lancet,2008

2. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy, an underestimated phenomenon;Otten;Arch Intern Med,2004

3. Labianca R, Floriani I, Isa L, et al. Alternating versus continuous “FOLFIRI” in advanced colorectal cancer (ACC): a randomized “GISCAD” trial. Proceedings ASCO; 2006 [abstract 3505].

4. Incidence of venous thromboembolism and its effect on survival among patients with common cancers;Chew;Arch Intern Med,2006

5. Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer;Feliu;Brit J Cancer,2005

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective but not pan-CDK inhibition abrogates 5-FU-driven tissue factor upregulation in colon cancer;Scientific Reports;2024-05-08

2. Active Nrf2 signaling flexibly regulates HO-1 and NQO-1 in hypoxic Gansu Zokor (Eospalax cansus);Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology;2023-02

3. Thrombotic Complications Associated with Immune Checkpoint Inhibitors;Cancers;2021-09-14

4. Survival of patients with cancer associated thrombosis at the Uganda Cancer Institute;ecancermedicalscience;2021-03-25

5. Kardiovaskuläre Spätfolgen der Chemotherapie bei Darmkrebspatienten;Der Onkologe;2021-03-18